Mechanisms and significance of eryptosis.
Suicidal death of erythrocytes (eryptosis) is characterized by cell shrinkage, membrane blebbing, activation of proteases, and phosphatidylserine exposure at the outer membrane leaflet. Exposed phosphatidylserine is recognized by macrophages that engulf and degrade the affected cells. Eryptosis is triggered by erythrocyte injury after several stressors, including oxidative stress. Besides caspase activation after oxidative stress, two signaling pathways converge to trigger eryptosis: (a) formation of prostaglandin E(2) leads to activation of Ca(2+)-permeable cation channels, and (b) the phospholipase A(2)-mediated release of platelet-activating factor activates a sphingomyelinase, leading to formation of ceramide. Increased cytosolic Ca(2+) activity and enhanced ceramide levels lead to membrane scrambling with subsequent phosphatidylserine exposure. Moreover, Ca(2+) activates Ca(2+)-sensitive K(2+) channels, leading to cellular KCl loss and cell shrinkage. In addition, Ca(2+) stimulates the protease calpain, resulting in degradation of the cytoskeleton. Eryptosis is inhibited by erythropoietin, which thus extends the life span of circulating erythrocytes. Eryptosis may be a mechanism of defective erythrocytes to escape hemolysis. Conversely, excessive eryptosis favors the development of anemia. Conditions with excessive eryptosis include iron deficiency, lead or mercury intoxication, sickle cell anemia, thalassemia, glucose 6- phosphate dehydrogenase deficiency, malaria, and infection with hemolysin-forming pathogens.
Lang
Florian
F
Department of Physiology, Eberhard-Karls-University of Tübingen, Germany. florian.lang@uni-tuebingen.de
Lang
Karl S
KS
Lang
Philipp A
PA
Huber
Stephan M
SM
Wieder
Thomas
T
D018798:Anemia, Iron-Deficiency / Q000097:blood / Q000378:metabolism; D000755:Anemia, Sickle Cell / Q000097:blood / Q000378:metabolism; D017209:Apoptosis / Q000502:physiology*; D002118:Calcium / Q000378:metabolism; D020169:Caspases / Q000378:metabolism; D002412:Cations / Q000378:metabolism; D016923:Cell Death / Q000502:physiology; D048429:Cell Size; D002518:Ceramides / Q000378:metabolism; D003600:Cytosol / Q000378:metabolism; D015232:Dinoprostone / Q000378:metabolism; D004789:Enzyme Activation; D004912:Erythrocytes / Q000166:cytology / Q000187:drug effects / Q000378:metabolism / Q000473:pathology / Q000502:physiology*; D004921:Erythropoietin / Q000378:metabolism / Q000494:pharmacology; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000097:blood / Q000378:metabolism; D006801:Humans; D007473:Ion Channels / Q000378:metabolism; D008954:Models, Biological; D018384:Oxidative Stress; D010718:Phosphatidylserines / Q000378:metabolism; D010972:Platelet Activating Factor / Q000378:metabolism; D013108:Sphingomyelin Phosphodiesterase / Q000378:metabolism; D013789:Thalassemia / Q000097:blood / Q000378:metabolism
D002412:Cations; D002518:Ceramides; D007473:Ion Channels; D010718:Phosphatidylserines; D010972:Platelet Activating Factor; D004921:Erythropoietin; D013108:Sphingomyelin Phosphodiesterase; D020169:Caspases; D015232:Dinoprostone; D002118:Calcium